Pharma-Bio Serv FY2025 revenue $9.0M (down ~5% YoY), net loss $0.1M; declares $0.075 special dividend

Pharma-Bio Serv, Inc.

Revenue $9.0M, decrease of $0.5M YoY; net loss $0.1M, improvement of $0.7M from prior year.
Special dividend of $0.075 per share approved; payable March 20, 2026 to holders of record Feb 27, 2026.
CEO cites portfolio rationalization, cost streamlining, and focus on Latin America and Europe for 2026.
Company traded on OTCQB under ticker PBSV; no explicit guidance provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.